AT ASCO 2016 - CARE™ Education€¦ · AT ASCO 2016 GUIDE TM FRAMED IN A CANADIAN PERSPECTIVE ... A phase Ib dose escalation study of the OX40 agonist MOXR0916 and the PD-L1 inhibitor

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)